EUVIMEDEUVIMED entdecken
Crossref

The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts

Pranit R Sunkara, Emily Chow iD, Jacob Waitzman iD, Ammar Sukari, John D Cramer

Head & Neck · 2025

DOI: 10.1002/hed.27949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Pranit R Sunkara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neutrophils, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hematological markers, such as neutrophils (ANC), lymphocyte (ALC), and neutrophil‐lymphocyte ratio (NLR), may serve as indicators of systemic inflammation and immune response in head and neck squamous cell carcinoma (HNSCC). However, their prognostic significance across HNSCC subtypes remains to be fully elucidated.

Methods

We conducted a secondary analysis of a randomized clinical trial involving patients with surgically resected HNSCC with either positive margins or extranodal extension. These patients received either adjuvant chemoradiation with or without lapatinib. We explored the correlation between pre‐therapy ANC, ALC, and NLR levels and overall survival (OS) as well as disease‐free survival (DFS). A sub‐group analysis examined potential links between these markers, primary tumor location, and HPV status.

Results

Of the 688 patients in the trial, we included 681 patients with documented pre‐therapy ANC and ALC values. High pre‐therapy ANC and ALC were significantly associated with reduced OS (HR, 1.56; 95% CI: 1.19–2.05) and (HR, 1.34; 95% CI: 1.01–1.79), respectively. High NLR did not significantly affect OS (HR, 1.09; 95% CI: 0.81–1.47). Subgroup analysis indicated significantly reduced OS in patients with high ANC across oropharyngeal, non‐oropharyngeal, and HPV‐negative subtypes. High ANC, ALC, and NLR did not impact DFS notably.

Conclusion

Elevated pre‐therapy ANC is strongly associated with decreased survival across all patients and subgroups, ALC was only significant in the general patient analysis. NLR's association with reduced OS was not statistically significant. These biomarkers may provide greater prognostic value in patients with oropharyngeal cancer and seemed to be more strongly associated with OS than DFS. Trial Registration Clinicaltrials.gov identifier: NCT00424255; URL: https://clinicaltrials.gov/ct2/show/study/NCT00424255

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsNeutrophilsSquamous Cell Carcinoma of Head and NeckAdultAgedFemaleHumansMaleMiddle AgedChemoradiotherapy, AdjuvantDisease-Free SurvivalLeukocyte CountLymphocyte CountLymphocytesPrognosisRandomized Controlled Trials as TopicClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

lymphocyteneutrophilsquamous cell carcinoma of head and necksurvival

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, Wayne State University, Detroit, Michigan, USA.
  • Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.

ORCID-Profile: Emily Chow, Jacob Waitzman

Zitieren

APA

Sunkara, P. R., Chow, E., Waitzman, J., Sukari, A., & Cramer, J. D. (2025). The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts. Head & Neck. https://doi.org/10.1002/hed.27949

Vancouver

Sunkara PR, Chow E, Waitzman J, Sukari A, Cramer JD. The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts. Head & Neck. 2025. doi:10.1002/hed.27949

BibTeX
@article{Sunkara2025,
  author = {Sunkara, Pranit R and Chow, Emily and Waitzman, Jacob and Sukari, Ammar and Cramer, John D},
  title = {The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27949}
}
Kostenlos starten →